Clinical trial
Treatment of Female Genital Schistosomiasis (FGS) With Praziquantel: A Proof-of-Concept Study
NCT04115072 is registered in ClinicalTrials.gov with Regionshospital Nordjylland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of Female Genital Schistosomiasis (FGS) With Praziquantel: A Proof-of-Concept Study
- Lead sponsor
- Regionshospital Nordjylland
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- September 3, 2019
- Completion date
- February 21, 2020
- Enrollment
- 116 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.